• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Program Can Prevent Adverse Childhood Experiences in Indigenous Children

Medically reviewed by Carmen Pope, BPharm. Last updated on Aug 13, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Aug. 13, 2024 -- A seven-session program that teaches skills to prevent adverse childhood experiences (ACEs) in a largely indigenous population shows promise for preventing ACEs, according to a study published online Aug. 13 in Pediatrics.

Katie M. Edwards, Ph.D., from the University of Nebraska in Lincoln, and colleagues randomly assigned 124 families (96 percent Indigenous; 90 percent with yearly income <$40,000) with 194 children aged 10 to 14 years to treatment (66 families and 173 individuals) or to wait-list (58 families and 145 individuals) control groups. Treatment included a seven-session program (Tiwahe Wicagwicayapi program [TWP]), which teaches skills to prevent ACEs that are rooted in Lakota culture, language, and history.

The researchers detected treatment effects, indicating reductions in the incidence of child ACEs (incidence rate ratio, 0.64), bullying victimization (odds ratio, 0.35), depression (d = −0.20), and externalizing behaviors (d = −0.23) compared with control participants; in addition, increases were seen in parent-child communication (g = 0.27) and child help-seeking behaviors (d = 0.28). The program prevented intimate partner violence victimization and perpetration for caregivers (incidence rate ratios, 0.36 and 0.45, respectively), as well as harsh parenting (g = −0.27), depression (d = −0.24), and increased emotional regulation, social support, and cultural connection (d = 0.37, 0.33, and 0.34, respectively).

"The TWP holds great promise to prevent ACEs among low-income, Indigenous children," the authors write. "The program also moved the needle on a number of other outcomes, showing potential promise for widespread public health impact among a highly structurally minoritized population."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted August 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.